subscribeSubscribe
Delcath Systems Reports Second Quarter 2024 Results and Business Highlights

Delcath Systems Reports Second Quarter 2024 Results and Business Highlights
BUSINESSWIRE
05 Aug 2024
Share Share
Delcath Systems to Host Second Quarter 2024 Earnings Call

Delcath Systems to Host Second Quarter 2024 Earnings Call
BUSINESSWIRE
22 Jul 2024
Share Share
Casi Pharma RenewsExclusive Distribution Agreement For Evomela

Casi Pharma RenewsExclusive Distribution Agreement For Evomela
PRNEWSWIRE
04 Mar 2022
Share Share
TAK1 blocker teams up with chemo to kill myeloma cells: study

TAK1 blocker teams up with chemo to kill myeloma cells: study
Arlene Weintraub FIERCEBIOTECH
18 Oct 2021
Share Share
Meeting highlights from Committee for Medicinal Products for Human Use (CHMP)

Meeting highlights from Committee for Medicinal Products for Human Use (CHMP)
EMA
18 Sep 2020
Share Share
CASI Pharma Announces Launch of EVOMELA® (melphalan injection) in China

CASI Pharma Announces Launch of EVOMELA® (melphalan injection) in China
PR NEWSWIRE
12 Aug 2019
Share Share
Takeda suffers another setback in its quest to expand myeloma drug’s reach

Takeda suffers another setback in its quest to expand myeloma drug’s reach
John Carroll ENDPTS
06 Jun 2019
Share Share
Deals and M&As this week: Alnylam Pharmaceuticals, Novartis

Deals and M&As this week: Alnylam Pharmaceuticals, Novartis
PHARMA TECH
25 Jan 2019
Share Share
Spectrum Pharmaceuticals sells marketed drugs to Aurobindo subsidiary for up to $300M

Spectrum Pharmaceuticals sells marketed drugs to Aurobindo subsidiary for up to $300M
Alaric Dearment MEDCITY NEWS
18 Jan 2019
Share Share
Janssen bags new EU approval for Darzalex

Janssen bags new EU approval for Darzalex
Selina McKee PHARMA TIMES
04 Sep 2018
Share Share